Celadon Pharmaceuticals plc (CEL) ORD GBP0.01
- Add to watchlist
- Create an alert
- This stock can be held in a
115.00p
120.00p
179.00p
£73.84 million
115.00p
110.00p
50.00p
n/a
0.00p (0.00%) Previous:
0.00p
90,868
n/a
1,500
Performance
Not available for this stock.
Fundamental data
Year ending: | 31/12/2022 | 31/12/2021 |
---|---|---|
Revenue (£m) | 0.02 | n/a |
Profit before tax (£m) | (18.12) | (4.80) |
Adjusted EPS (p): | (29.50) | (7.87) |
P/E ratio | n/a | n/a |
PEG | n/a | n/a |
EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Celadon starts supplying cannabis for two contracts
14 December 2023 11:16
-
Celadon's new finance chief to join later in January
13 January 2023 13:24
-
Celadon confident in approval for its cannabis medicine facility
22 December 2022 14:50
-
Product Supplied to First Two Sales Contracts
14 December 2023 07:00
-
Fundraise, Update on Future CLN Financing & TVR
12 December 2023 14:00
-
New European Sales Contract
16 November 2023 07:00
Recent trade data is unavailable. We will be replacing it, however in the meantime the information is available on the London Stock Exchange website.
Annual & interim reports
Annual & interim reports are not available for this stock.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.